《港股》恆指半日跌121點 小鵬回吐5% 中生製藥升15%創逾三年高
中美達成貿易共識,美國不改變中國關稅稅率及取消部分出口管制,據報中國亦恢復磁鐵稀土出口6個月。港股早市回吐。恆指低開143點,初段跌213點低見24,153點後跌幅收窄,半日跌121點或0.5%,報24,244點;國指跌45點或0.5%,報8,820點;恆生科技指數跌57點或1.1%,報5,393點。大市半日成交總額1,256.39億元。
科技股方面,阿里(09988.HK)跌2%報116元,快手(01024.HK)跌4.7%,騰訊(00700.HK)、嗶哩嗶哩(09626.HK)、百度(09888.HK)及京東(09618.HK)跌0.6%至0.8%,新東方(09901.HK)及中芯(00981.HK)跌2.2%及1.7%。美團(03690.HK)及網易(09999.HK)升0.3%及0.5%。此外,網易雲音樂(09899.HK)升6.6%,平安好醫生(01833.HK)、金軟(03888.HK)、騰訊音樂(01698.HK)及心動(02400.HK)升3.8%至4.9%。
車股方面,小鵬(09868.HK)G7預售46分鐘小訂突破1萬台,股價回吐5%。零跑(09863.HK)、比亞迪(01211.HK)及蔚來(09866.HK)跌2.1%至2.7%,小米(01810.HK)跌1.7%。花旗報告指內地規定車企60天內向供應商付款將影響車企利息收入。地平線(09660.HK)折讓約6.85%配股淨籌46.7億,股價跌4.6%。電池股寧德時代(03750.HK)升0.5%。
醫藥股見追捧,中生製藥(01177.HK)升15.1%報5.49元,高見5.62元見逾三年高。中生製藥資本市場負責人稱,近期將有一筆標誌性重磅對外授權交易落地。綠葉製藥(02186.HK)、百濟神州(06160.HK)及康哲藥業(00867.HK)升5.3%至6.6%;藥明巨諾-B(02126.HK)、藥明合聯(02268.HK)、藥明康德(02359.HK)、翰森(03692.HK)及藥明生物(02269.HK)升3.6%至5.3%。多隻消費股偏軟,油價急升近半成,航空股國航(00753.HK)及東航(00670.HK)跌2.8%及3.8%,潤啤(00291.HK)、海底撈(06862.HK)、潤飲(02460.HK)及滔搏(06110.HK)跌2.4%至3.1%,百威亞太(01876.HK)跌4.4%。
物流股順豐控股(06936.HK)升8.4%報45.75元,盤中見45.95元上市新高。泡泡瑪特(09992.HK)升1.2%報273元,盤中見283.4元新高。金飾零售股老鋪黃金(06181.HK)反彈4.4%。
金融股方面,匯控(00005.HK)及港交所(00388.HK)跌0.3%及0.8%,友邦(01299.HK)跌1.5%。內險股續受捧,中國太平(00966.HK)、人保(01339.HK)、國壽(02628.HK)及太保(02601.HK)升2.5%至3.4%。券商股國泰海通(02611.HK)升2.6%。美伊緊張局勢升級,金股紫金(02899.HK)及招金(01818.HK)升逾5%,山東黃金(01787.HK)升2.9%。航運股中遠海控(01919.HK)跌3.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.